BHC vs. TLRY, CRON, WEED, DNTL, SIA, WELL, GUD, ACB, OGI, and CPH
Should you be buying Bausch Health Companies stock or one of its competitors? The main competitors of Bausch Health Companies include Tilray Brands (TLRY), Cronos Group (CRON), Canopy Growth (WEED), dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Organigram (OGI), and Cipher Pharmaceuticals (CPH). These companies are all part of the "medical" sector.
Bausch Health Companies (TSE:BHC) and Tilray Brands (TSE:TLRY) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, community ranking, valuation and earnings.
In the previous week, Bausch Health Companies had 6 more articles in the media than Tilray Brands. MarketBeat recorded 7 mentions for Bausch Health Companies and 1 mentions for Tilray Brands. Bausch Health Companies' average media sentiment score of 0.57 beat Tilray Brands' score of -0.36 indicating that Bausch Health Companies is being referred to more favorably in the media.
Bausch Health Companies has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 2.38, suggesting that its stock price is 138% more volatile than the S&P 500.
80.0% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 12.2% of Tilray Brands shares are owned by institutional investors. 0.9% of Bausch Health Companies shares are owned by insiders. Comparatively, 1.2% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Bausch Health Companies has a net margin of -5.07% compared to Tilray Brands' net margin of -47.35%. Tilray Brands' return on equity of -9.69% beat Bausch Health Companies' return on equity.
Tilray Brands has lower revenue, but higher earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Bausch Health Companies presently has a consensus target price of C$9.00, indicating a potential upside of 3.33%. Tilray Brands has a consensus target price of C$2.95, indicating a potential upside of 17.06%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Bausch Health Companies.
Bausch Health Companies received 39 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 66.10% of users gave Bausch Health Companies an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.
Summary
Bausch Health Companies and Tilray Brands tied by winning 8 of the 16 factors compared between the two stocks.
Get Bausch Health Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bausch Health Companies Competitors List
Related Companies and Tools
